Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Inhibition of Akt/Survivin Pathway Synergizes the Antileukemia Effect of Nutlin-3 in Acute Lymphoblastic Leukemia Cells.

Ningxi Zhu, MD, PhD, Lubing Gu, MD, Muxiang Zhou, MD

Blood (2007) 110 (11): 2790.

https://doi.org/10.1182/blood.V110.11.2790.2790

Published: 2007

Journal Articles

The MDM2 Antagonist Nutlin-3 Is a Potent Inducer of Apoptosis in Pediatric Acute Lymphoblastic Leukemia Cells with Wild-Type p53 and Overexpression of MDM2.

Lubing Gu, MD, Ningxi Zhu, MD, PhD, Harry W. Findley, PhD, Muxiang Zhou, MD

Blood (2007) 110 (11): 4277.

https://doi.org/10.1182/blood.V110.11.4277.4277

Published: 2007

Journal Articles

Contribution of STAT3 to Activation of Survivin by Granulocyte-Macrophage Colony-Stimulating Factor in CD34+ Cells.

Lubing Gu, MD, Kuang-Yueh Chiang, MD, Ningxi Zhu, MD,PhD, Harry W. Findley, PhD, Muxiang Zhou, MD

Blood (2006) 108 (11): 4202.

https://doi.org/10.1182/blood.V108.11.4202.4202

Published: 2006

Journal Articles

Endogenous TNFα Mediates Cell Survival and Chemotherapy Resistance by Activating the PI3K/Akt Pathway in Childhood Acute Lymphoblastic Leukemia.

Lubing Gu, MD, Harry W. Findley, PhD, Ningxi Zhu, MD, PhD, Muxiang Zhou, MD

Blood (2005) 106 (11): 4551.

https://doi.org/10.1182/blood.V106.11.4551.4551

Published: 2005

Journal Articles

Vitamin K3 Selectively Induces Apoptosis in Acute Lymphoblastic Leukemia Cells with Constitutive Activation of IKKα/NF-kB Activation.

Ningxi Zhu, MD, PhD, Lubing Gu, MD, Harry W. Findley, PhD, Kuang-Yueh Chiang, MD, Muxiang Zhou, MD

Blood (2005) 106 (11): 859.

https://doi.org/10.1182/blood.V106.11.859.859

Published: 2005

Journal Articles

Loss of PTEN Expression Induces NF-kB Via PI3K/Akt Pathway Involving Resistance to Chemotherapy in Acute Lymphoblastic Leukemia Cell Lines.

Lubing Gu, MD, Ningxi Zhu, MD, PhD, Harry W. Findley, PhD, Muxiang Zhou, MD

Blood (2004) 104 (11): 4438.

https://doi.org/10.1182/blood.V104.11.4438.4438

Published: 2004

Journal Articles

An Alternatively Spliced Survivin Variant Is Positively Regulated by p53 and Sensitizes Leukemia Cells to Chemotherapy.

Ningxi Zhu, MD, PhD, Lubing Gu, MD, Harry W. Findley, PhD, Fengzhi Li, PhD, Muxiang Zhou, MD

Blood (2004) 104 (11): 3497.

https://doi.org/10.1182/blood.V104.11.3497.3497

Published: 2004

NARROW

Inhibition of Akt/Survivin Pathway Synergizes the Antileukemia Effect of Nutlin-3 in Acute Lymphoblastic Leukemia Cells.

The MDM2 Antagonist Nutlin-3 Is a Potent Inducer of Apoptosis in Pediatric Acute Lymphoblastic Leukemia Cells with Wild-Type p53 and Overexpression of MDM2.

Contribution of STAT3 to Activation of Survivin by Granulocyte-Macrophage Colony-Stimulating Factor in CD34+ Cells.

Endogenous TNFα Mediates Cell Survival and Chemotherapy Resistance by Activating the PI3K/Akt Pathway in Childhood Acute Lymphoblastic Leukemia.

Vitamin K3 Selectively Induces Apoptosis in Acute Lymphoblastic Leukemia Cells with Constitutive Activation of IKKα/NF-kB Activation.

Loss of PTEN Expression Induces NF-kB Via PI3K/Akt Pathway Involving Resistance to Chemotherapy in Acute Lymphoblastic Leukemia Cell Lines.

An Alternatively Spliced Survivin Variant Is Positively Regulated by p53 and Sensitizes Leukemia Cells to Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Inhibition of Akt/Survivin Pathway Synergizes the Antileukemia Effect of Nutlin-3 in Acute Lymphoblastic Leukemia Cells.

The MDM2 Antagonist Nutlin-3 Is a Potent Inducer of Apoptosis in Pediatric Acute Lymphoblastic Leukemia Cells with Wild-Type p53 and Overexpression of MDM2.

Contribution of STAT3 to Activation of Survivin by Granulocyte-Macrophage Colony-Stimulating Factor in CD34+ Cells.

Endogenous TNFα Mediates Cell Survival and Chemotherapy Resistance by Activating the PI3K/Akt Pathway in Childhood Acute Lymphoblastic Leukemia.

Vitamin K3 Selectively Induces Apoptosis in Acute Lymphoblastic Leukemia Cells with Constitutive Activation of IKKα/NF-kB Activation.

Loss of PTEN Expression Induces NF-kB Via PI3K/Akt Pathway Involving Resistance to Chemotherapy in Acute Lymphoblastic Leukemia Cell Lines.

An Alternatively Spliced Survivin Variant Is Positively Regulated by p53 and Sensitizes Leukemia Cells to Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only